• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人先天性心脏病患者心脏再同步治疗的长期疗效

Long-term outcomes of cardiac resynchronization therapy in adult congenital heart disease.

作者信息

Leyva Francisco, Zegard Abbasin, Qiu Tian, de Bono Joseph, Thorne Sara, Clift Paul, Marshall Howard, Hudsmith Lucy

机构信息

Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham, UK.

Quality and Outcomes Research Unit, Queen Elizabeth Hospital, Birmingham, UK.

出版信息

Pacing Clin Electrophysiol. 2019 Jun;42(6):573-580. doi: 10.1111/pace.13670. Epub 2019 Apr 17.

DOI:10.1111/pace.13670
PMID:30908673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6850101/
Abstract

BACKGROUND AND AIMS

Randomized, controlled trials of cardiac resynchronization therapy (CRT) excluded patients with adult congenital heart disease (ACHD). We sought to explore long-term clinical outcomes.

METHODS AND RESULTS

In this single-center, observational study, events were collected from hospital records on patients with structural ACHD (sACHD) and adults with ischemic (ICM) or nonischemic (NICM) cardiomyopathy undergoing CRT. Patients with sACHD (n = 23, age: 41.6 ± 13.5 years [mean ± standard deviation]) and adults with ICM (n = 533) or NICM (n = 458) were followed-up for 4.1 years (median; interquartile range: 2.2-6.1). Total mortality was 5/23 (21.7%; 4.4 per 100 person-years) in sACHD, 221/533 (41.5%; 11.8 per 100 person-years) in ICM, and 154/458 (33.6%; 9.7 per 100 person-years) in NICM. In univariate analyses, total mortality in sACHD was lower than in ICM (hazard ratio [HR]: 0.38; 95% confidence interval [CI] 0.15-0.91), but similar to NICM (HR: 0.48, 95% CI 0.20-1.16). Cardiac mortality in sACHD was similar to ICM (HR: 0.78, 95% CI 0.32-1.92) and NICM (HR: 1.12, 95% CI 0.45-2.78). Heart failure (HF) hospitalization rates were similar to ICM (HR: 0.44, 95% CI 0.11-1.77) and NICM (HR: 0.75, 95% CI 0.18-3.08). In multivariate analyses, no differences emerged in total mortality, cardiac mortality, or HF hospitalization between sACHD and NICM or ICM, after adjustment for age, sex, New York Heart Association class, diabetes, atrial rhythm, QRS duration, QRS morphology, systemic ventricular ejection fraction, and medical therapy.

CONCLUSION

Total mortality, cardiac mortality, and HF hospitalization after CRT in patients with sACHD was similar to adults with ICM or NICM.

摘要

背景与目的

心脏再同步治疗(CRT)的随机对照试验排除了患有成人先天性心脏病(ACHD)的患者。我们试图探究其长期临床结局。

方法与结果

在这项单中心观察性研究中,我们从医院记录中收集了患有结构性ACHD(sACHD)的患者以及接受CRT的缺血性心肌病(ICM)或非缺血性心肌病(NICM)成人患者的相关事件。对sACHD患者(n = 23,年龄:41.6±13.5岁[均值±标准差])以及ICM成人患者(n = 533)或NICM成人患者(n = 458)进行了4.1年的随访(中位数;四分位间距:2.2 - 6.1)。sACHD患者的总死亡率为5/23(21.7%;每100人年4.4例),ICM患者为221/533(41.5%;每100人年11.8例),NICM患者为154/458(33.6%;每100人年9.7例)。在单因素分析中,sACHD患者的总死亡率低于ICM患者(风险比[HR]:0.38;95%置信区间[CI] 0.15 - 0.91),但与NICM患者相似(HR:0.48,95% CI 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/6850101/1026352ad9e1/PACE-42-573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/6850101/25da130bd8dc/PACE-42-573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/6850101/1026352ad9e1/PACE-42-573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/6850101/25da130bd8dc/PACE-42-573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/6850101/1026352ad9e1/PACE-42-573-g002.jpg

相似文献

1
Long-term outcomes of cardiac resynchronization therapy in adult congenital heart disease.成人先天性心脏病患者心脏再同步治疗的长期疗效
Pacing Clin Electrophysiol. 2019 Jun;42(6):573-580. doi: 10.1111/pace.13670. Epub 2019 Apr 17.
2
Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.超声心动图引导下左心室导线放置在缺血性与非缺血性心肌病患者心脏再同步治疗中的应用。
Heart Rhythm. 2014 Apr;11(4):614-9. doi: 10.1016/j.hrthm.2014.01.023. Epub 2014 Jan 23.
3
Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.心脏再同步治疗伴或不伴除颤的长期临床结局:心肌病病因的影响。
Europace. 2018 Nov 1;20(11):1804-1812. doi: 10.1093/europace/eux357.
4
Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.在心脏再同步治疗中添加植入式心脏复律除颤器与缺血性心肌病患者的长期生存率提高相关,但与非缺血性心肌病患者无关。
Europace. 2016 Mar;18(3):413-9. doi: 10.1093/europace/euv212. Epub 2015 Sep 15.
5
Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.病因对接受心脏再同步治疗的心力衰竭患者预后的影响:一项荟萃分析。
PLoS One. 2014 Apr 14;9(4):e94614. doi: 10.1371/journal.pone.0094614. eCollection 2014.
6
Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.非缺血性心肌病患者心脏再同步治疗联合或不联合除颤的疗效。
J Am Coll Cardiol. 2017 Sep 5;70(10):1216-1227. doi: 10.1016/j.jacc.2017.07.712.
7
Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.左束支传导阻滞相关性特发性非缺血性心肌病患者心脏再同步治疗后的性别特异性临床结局:一项NEOLITH II子研究
Ann Noninvasive Electrocardiol. 2019 Jul;24(4):e12641. doi: 10.1111/anec.12641. Epub 2019 Mar 27.
8
Cardiac Resynchronization Therapy with Defibrillator in Ischemic Versus Nonischemic Cardiomyopathy.心脏再同步治疗伴或不伴缺血性心肌病的除颤器。
Int Heart J. 2024;65(5):823-832. doi: 10.1536/ihj.24-023.
9
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.左心室中层心肌纤维化作为非缺血性心肌病患者心脏再同步治疗后死亡率和发病率的预测因子。
J Am Coll Cardiol. 2012 Oct 23;60(17):1659-67. doi: 10.1016/j.jacc.2012.05.054. Epub 2012 Sep 26.
10
[A multi-center study on the long-term mortality and related risk factors in patients with chronic heart failure receiving resynchronization therapy].[一项关于接受心脏再同步治疗的慢性心力衰竭患者长期死亡率及相关危险因素的多中心研究]
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Nov 24;44(11):951-955. doi: 10.3760/cma.j.issn.0253-3758.2016.11.010.

引用本文的文献

1
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023年美国心律学会/亚太心律学会/拉丁美洲心律学会关于避免和减轻心力衰竭的心脏生理性起搏指南。
J Arrhythm. 2023 Aug 2;39(5):681-756. doi: 10.1002/joa3.12872. eCollection 2023 Oct.
2
Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices.成人先天性心脏病心力衰竭的新型治疗策略:药物与器械方面
Curr Heart Fail Rep. 2023 Oct;20(5):401-416. doi: 10.1007/s11897-023-00621-1. Epub 2023 Aug 16.
3
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.

本文引用的文献

1
Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy.从起搏器升级为心脏再同步治疗后的临床结局
Pacing Clin Electrophysiol. 2018 Mar;41(3):290-298. doi: 10.1111/pace.13287. Epub 2018 Feb 16.
2
Cardiac resynchronization therapy in adults with congenital heart disease.成人先天性心脏病的心脏再同步治疗。
Europace. 2018 Feb 1;20(2):315-322. doi: 10.1093/europace/euw386.
3
Cardiac resynchronization therapy for various systemic ventricular morphologies in patients with congenital heart disease.
2023 年 HRS/APHRS/LAHRS 心脏生理起搏指南:预防和减轻心力衰竭。
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.
4
Cardiac Resynchronization Therapy for Adult Patients With a Failing Systemic Right Ventricle: A Multicenter Study.心脏再同步治疗衰竭性右心室的成人患者:一项多中心研究。
J Am Heart Assoc. 2022 Nov 15;11(22):e025121. doi: 10.1161/JAHA.121.025121. Epub 2022 Nov 8.
5
Long-Term Outcome of Patients With Congenital Heart Disease Undergoing Cardiac Resynchronization Therapy.先天性心脏病患者接受心脏再同步治疗的长期预后。
J Am Heart Assoc. 2021 Mar 16;10(6):e018302. doi: 10.1161/JAHA.120.018302. Epub 2021 Mar 13.
6
State of Cardiac Implantable Electronic Devices in Congenital Heart Disease: A 2019 Update.先天性心脏病中心脏植入式电子设备的现状:2019年更新
J Innov Card Rhythm Manag. 2019 Dec 15;10(12):3940-3943. doi: 10.19102/icrm.2019.101207. eCollection 2019 Dec.
先天性心脏病患者不同系统性心室形态的心脏再同步治疗。
Circ J. 2015;79(3):649-55. doi: 10.1253/circj.CJ-14-0395. Epub 2015 Jan 9.
4
PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).PACES/HRS关于成人先天性心脏病心律失常识别与管理的专家共识声明:由儿科与先天性电生理学会(PACES)和心律学会(HRS)合作制定。得到了PACES、HRS、美国心脏病学会(ACC)、美国心脏协会(AHA)、欧洲心律协会(EHRA)、加拿大心律协会(CHRS)以及国际成人先天性心脏病学会(ISACHD)管理机构的认可。
Can J Cardiol. 2014 Oct;30(10):e1-e63. doi: 10.1016/j.cjca.2014.09.002.
5
20 years of cardiac resynchronization therapy.20 年心脏再同步治疗。
J Am Coll Cardiol. 2014 Sep 9;64(10):1047-58. doi: 10.1016/j.jacc.2014.06.1178.
6
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
7
Cardiac resynchronization therapy in adult patients with repaired tetralogy of fallot and left ventricular systolic dysfunction.法洛四联症修复术后合并左心室收缩功能障碍的成年患者的心脏再同步治疗
Pacing Clin Electrophysiol. 2014 Mar;37(3):321-8. doi: 10.1111/pace.12284. Epub 2013 Oct 25.
8
Biventricular pacing for atrioventricular block and systolic dysfunction.双心室起搏治疗房室传导阻滞和收缩功能障碍。
N Engl J Med. 2013 Apr 25;368(17):1585-93. doi: 10.1056/NEJMoa1210356.
9
Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution.儿科和先天性心脏病中的心脏再同步治疗(及多部位起搏):单一机构的五年经验
J Cardiovasc Electrophysiol. 2009 Jan;20(1):58-65. doi: 10.1111/j.1540-8167.2008.01274.x. Epub 2008 Sep 3.
10
Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study.在心力衰竭病情恶化的永久起搏患者中,从单腔右心室起搏升级为双心室起搏:RD-CHF研究。
Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S23-30. doi: 10.1111/j.1540-8159.2007.00598.x.